Thyroid Malignancy among Fine Needle Aspiration Cytology of Thyroid Lesions in a Tertiary Care Centre
- PMID: 38410013
- PMCID: PMC10924497
- DOI: 10.31729/jnma.8396
Thyroid Malignancy among Fine Needle Aspiration Cytology of Thyroid Lesions in a Tertiary Care Centre
Abstract
Introduction: The most prevalent endocrine cancer in the world is thyroid cancer, and its incidence is on the rise. The distinction between benign and malignant thyroid nodules must be made, which is why fine needle aspiration cytology of thyroid lesion is necessary and required. This study aimed to find out the prevalence of thyroid malignancy among fine needle aspiration cytology of thyroid lesions in a tertiary care centre.
Methods: A descriptive cross-sectional study was conducted among fine needle aspiration cytology of thyroid lesions in a tertiary care centre after obtaining ethical approval from the Institutional Review Committee. Data from 13 April 2020 to 13 April 2023 was collected between 19 May 2023 to 19 June 2023. All the patients with complete hospital record data were included in this study. However, repetitive fine needle aspiration cytology of thyroid lesion were excluded from the study. Fine needle aspiration cytology diagnoses were categorized in this study as per the Bethesda system for reporting thyroid cytopathology. The point estimate was calculated at a 95% Confidence Interval.
Results: Among 398 fine needle aspiration cytology of thyroid lesions, thyroid malignancy was seen in 12 (3.02%) (1.34-4.70, 95% Confidence Interval) patients.
Conclusions: The prevalence of thyroid malignancy was found to be lower than other studies done in similar settings.
Keywords: cytology; malignancy; prevalence; thyroid.
Conflict of interest statement
Similar articles
-
Mean Micronuclei Score in Fine-Needle Aspiration Cytology of Patients with Malignant Breast Lump in the Department of Pathology in a Tertiary Care Centre: A Descriptive Cross-sectional Study.JNMA J Nepal Med Assoc. 2022 Dec 1;60(256):1037-1040. doi: 10.31729/jnma.7909. JNMA J Nepal Med Assoc. 2022. PMID: 36705103 Free PMC article.
-
Ultrasound Parameters of Thyroid Nodules and the Risk of Malignancy: A Retrospective Analysis.Cancer Control. 2020 Jan-Dec;27(1):1073274820945976. doi: 10.1177/1073274820945976. Cancer Control. 2020. Retraction in: Cancer Control. 2023 Jan-Dec;30:10732748231190123. doi: 10.1177/10732748231190123. PMID: 33035078 Free PMC article. Retracted.
-
[On-site fine-needle aspiration cytology of thyroid nodules. Quality assurance of the Bethesda System for Reporting Thyroid Cytopathology (2008)].Orv Hetil. 2015 Oct 11;156(41):1661-6. doi: 10.1556/650.2015.30268. Orv Hetil. 2015. PMID: 26551169 Hungarian.
-
False positive cases in thyroid cytopathology - the experience of a single laboratory and a systematic review.Cytopathology. 2021 Jul;32(4):493-504. doi: 10.1111/cyt.12984. Epub 2021 Apr 29. Cytopathology. 2021. PMID: 33914381
-
Analysis of the bethesda system for reporting thyroid cytopathology and similar precursor thyroid cytopathology reporting schemes.Adv Anat Pathol. 2012 Sep;19(5):313-9. doi: 10.1097/PAP.0b013e3182666398. Adv Anat Pathol. 2012. PMID: 22885380 Review.
Cited by
-
Location based BRAF V600E mutation status and dimension patterns of sporadic thyroid nodules: a population-based study.BMC Cancer. 2025 Mar 6;25(1):406. doi: 10.1186/s12885-025-13776-y. BMC Cancer. 2025. PMID: 40050757 Free PMC article.
References
-
- Alyousif H, Adam I, Alamin NA, Sid Ahmed MA, Al Saeed A, Hassoni AH, et al. The prevalence and associated predictors for Bethesda III-VI for reporting thyroid cytopathology in Royal Commission Hospital, Kingdom of Saudi Arabia. Ther Adv Endocrinol Metab. 2022;13:20420188221122486. doi: 10.1177/20420188221122486. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous